Diagnostics & imaging AI · Ambient documentation
Abridge
Abridge is an ambient clinical documentation product for health systems and large ambulatory groups. It listens to the visit, drafts the note, and is built to write back into the EHR, especially Epic.
Strong fit
- Health systems standardizing ambient documentation on Epic
- Specialties where Abridge's notes are strong
- Groups that track how often clinicians edit notes and how much charting they do after hours
Weak fit
- Clinics that need to work offline or with weak internet connections
- Organizations without IT time to connect it to the EHR
- Buyers who expect clinicians never to review AI drafts
Bottom line
Abridge is worth using for health systems on Epic that want ambient AI to draft clinical notes. It suits organizations that can give the rollout steady IT and clinical informatics attention.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Abridge sells ambient clinical documentation to health systems and large ambulatory groups. It records the visit, drafts the note, and sends it into the EHR so clinicians have less to rewrite. Health systems have begun publishing how much after-hours charting time these tools cut, and Abridge's customer stories on that point are stronger than those of most of its peers. Abridge says it will support more than 100 million patient-clinician conversations at more than 300 U.S. health systems in 2026.
Beyond the demo, ambient documentation vendors differ in three ways: how well notes hold up in each specialty, how often clinicians must edit or correct the drafts in daily use, and whether health information management and compliance teams approve the workflow. Abridge has invested heavily in all three. It has built ways to work inside Epic, including writing notes back into the EHR, and has worked on note quality across specialties.
Abridge's score reflects strong customer results and product depth, and pricing clarity is its weakest area because contracts are negotiated with each health system. Hospitals still have to manage network connections and microphones on the floor, some specialties have gaps, and implementation takes real time from IT and the chief medical information officer's team.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Abridge | 8.4 | 7.8 |
| Freed | 8.0 | 7.6 |
| Suki | 7.8 | 7.6 |
| Heidi Health | 7.7 | 8.0 |
| Ambience | 7.6 | 7.3 |
| Nabla | 7.6 | 7.2 |
| Eleos Health | 7.4 | 7.0 |
| DeepScribe | 7.3 | 7.0 |
| Tali AI | 6.8 | 7.2 |
Pricing
| Item | Detail |
|---|---|
| Model | Contracts negotiated with each health system's purchasing team, usually priced per clinician or per visit. |
| What usually drives cost | License fees, plus the work to connect to the EHR and to change how clinicians document visits. |
| What to ask before you buy | The cost at your number of clinicians or visits, with EHR connection and training costs listed separately. |
| Published pricing | Prices are quoted for each health system and are not listed on the website. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Abridge to function | |
| Epic or another supported EHR, with a plan for writing notes back into it | Without an approved way into the chart, drafts stay outside it and clinicians end up rewriting notes anyway. |
| Support from the chief medical information officer or clinical informatics team | Pilots stall when no clinical leader sets targets for how often notes are edited and rules for review. |
| IT time for devices, single sign-on, and EHR setup | Microphone setup and connection work get pushed behind other EHR projects unless you reserve time for them. |
| Clinicians willing to review AI drafts every visit | Clinicians catch errors in AI drafts before the notes enter the chart. |
| A pilot in a few specialties before rolling out everywhere | Launching in every specialty at once hides which ones produce good notes. |
| What will maximize your value | |
| Track note edits and after-hours charting by specialty | Edit rates and after-hours charting show whether time savings hold up in daily use. |
| Approval from health information management and compliance on recording rules | Workflows that were never approved get pulled after launch, and adoption is lost. |
| Clinician champions who coach peers on when to rewrite a draft and when to accept it | Peer habits decide whether the tool sticks or becomes a draft window nobody reads. |
| Standard internet and microphone setups for exam rooms and clinics | Equipment problems in the room show up in reports as if the AI had failed. |
| Willingness to pause the rollout while clinicians are still editing heavily | Adding specialties before note quality settles teaches clinicians to distrust the tool. |
| Deal-breakers | |
| Your EHR is not supported, or writing notes back is promised for later with no date. | |
| Leadership expects AI notes to go into the chart without clinician review. | |
| No clinical informatics leader will run the pilots and set editing targets. | |
| IT cannot make room for the setup work in the next two quarters. | |
| Your clinics mainly need to work offline or with very weak internet. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | From signing to kickoff | 2-6 weeks for security review, lining up EHR contacts, and choosing a pilot specialty |
| 2 | From kickoff to first use | 8-16 weeks for a pilot in one specialty on a supported Epic setup |
| 3 | From first use to steady results | 3-6 months of cutting down how often clinicians edit the notes before adding more specialties |
Leadership
Recent news
- October 2026: Abridge signed an enterprise-wide agreement with the University of Texas System, whose hospitals and clinics logged nearly 11.7 million outpatient visits in the past year, after a pilot in which recording clinicians grew 73% over 12 months.
- June 2026: Abridge announced a strategic investment from Eli Lilly and a collaboration with NVIDIA on a foundation model for clinical conversations, as it expands payer and life-sciences workflows.
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.